CD44 and cancer: In cancer-associated fibroblasts and tumor-associated macrophages, this same CD44/integrin–PI3K/AKT axis sustains cell survival, motility, and immune regulatory functions, underscoring its central role in tumor progression and therapeutic resistance (Fig. 1).